Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Blume, J. Davis, K. Schmaling (1999)Neurocognitive dysfunction in dually-diagnosed patients: a potential roadblock to motivating behavior change.
Journal of psychoactive drugs, 31 2
S. Lista, J. Molinuevo, E. Cavedo, L. Rami, P. Amouyel, S. Teipel, F. Garaci, N. Toschi, M. Habert, K. Blennow, H. Zetterberg, S. O'Bryant, L. Johnson, S. Galluzzi, A. Bokde, K. Broich, K. Herholz, H. Bakardjian, B. Dubois, F. Jessen, M. Carrillo, P. Aisen, H. Hampel (2015)Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.
Journal of Alzheimer's disease : JAD, 48 Suppl 1
T. Dassanayake, P. Michie, A. Jones, G. Carter, T. Mallard, I. Whyte (2012)Cognitive Impairment in Patients Clinically Recovered From Central Nervous System Depressant Drug Overdose
Journal of Clinical Psychopharmacology, 32
K. Nylund, T. Asparouhov, B. Muthén (2007)Deciding on the Number of Classes in Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation Study
Structural Equation Modeling: A Multidisciplinary Journal, 14
S. Darke, J. Sims, S. McDonald, W. Wickes (2000)Cognitive impairment among methadone maintenance patients.
Addiction, 95 5
Nicole Ridley, J. Batchelor, B. Draper, A. Demirkol, N. Lintzeris, A. Withall (2018)Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke’s Cognitive Examination–Revised, and Montreal Cognitive Assessment
Journal of Clinical and Experimental Neuropsychology, 40
R. Paul (2019)Neurocognitive Phenotyping of HIV in the Era of Antiretroviral Therapy
Current HIV/AIDS Reports, 16
M. Bates, A. Pawlak, J. Tonigan, J. Buckman (2006)Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change.
Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 20 3
Katherine Masyn (2013)Latent Class Analysis and Finite Mixture Modeling
M. Mintzer, M. Copersino, M. Stitzer (2005)Opioid abuse and cognitive performance.
Drug and alcohol dependence, 78 2
H. Thein, P. Maruff, M. Krahn, J. Kaldor, D. Koorey, B. Brew, B. Brew, G. Dore, G. Dore (2007)Cognitive function, mood and health‐related quality of life in hepatitis C virus (HCV)‐monoinfected and HIV/HCV‐coinfected individuals commencing HCV treatment *
HIV Medicine, 8
F. Lima, F. Rabelo-da-Ponte, J. Bücker, L. Czepielewski, Mathias Hasse-Sousa, Raissa Telesca, B. Solé, M. Reinares, E. Vieta, A. Rosa (2019)Identifying cognitive subgroups in bipolar disorder: A cluster analysis.
Journal of affective disorders, 246
A. Kamarulzaman, F. Altice (2015)Challenges in managing HIV in people who use drugs
Current Opinion in Infectious Diseases, 28
Pria Anand, S. Springer, M. Copenhaver, F. Altice (2010)Neurocognitive Impairment and HIV Risk Factors: A Reciprocal Relationship
AIDS and Behavior, 14
(1977)The CES-D scale: a self-report depression scale for research in the general population
C. Souza, G. Oliveira, M. Foss, V. Tumas (2016)Cluster analysis of cognitive performance in a sample of patients with Parkinson's disease
Dementia & Neuropsychologia, 10
Ifeoma Ezeabogu, M. Copenhaver, Jessica Potrepka (2012)The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS
AIDS Care, 24
Bridget Burmester, J. Leathem, P. Merrick (2016)Subjective Cognitive Complaints and Objective Cognitive Function in Aging: A Systematic Review and Meta-Analysis of Recent Cross-Sectional Findings
Neuropsychology Review, 26
Eri Nakagami, M. Hoe, J. Brekke (2010)The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia.
Schizophrenia bulletin, 36 5
P. Rapeli, R. Kivisaari, T. Autti, S. Kähkönen, Varpu Puuskari, Olga Jokela, H. Kalska (2006)Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls
BMC Psychiatry, 6
Misty Hawkins, Julie Schaefer, J. Gunstad, Mary Dolansky, J. Redle, R. Josephson, S. Moore, J. Hughes (2015)What is your patient's cognitive profile? Three distinct subgroups of cognitive function in persons with heart failure.
Applied nursing research : ANR, 28 2
P. Bach, Ulrich Frischknecht, I. Reinhard, N. Bekier, T. Demirakca, G. Ende, S. Vollstädt-Klein, F. Kiefer, D. Hermann (2019)Impaired working memory performance in opioid-dependent patients is related to reduced insula gray matter volume: a voxel-based morphometric study
European Archives of Psychiatry and Clinical Neuroscience, 271
S. Darke, S. McDonald, S. Kaye, M. Torok (2012)Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users.
Drug and alcohol dependence, 126 3
D. Carol, Ryff, Robert, F., Krueger (2021)OXFORD LIBRARY OF PSYCHOLOGY
(1998)Mplus user's guide
Alex Baldacchino, David Balfour, F. Passetti, G. Humphris, Keith Matthews (2012)Neuropsychological consequences of chronic opioid use: A quantitative review and meta-analysis
Neuroscience & Biobehavioral Reviews, 36
J. Morgenstern, M. Bates (1999)Effects of executive function impairment on change processes and substance use outcomes in 12-step treatment.
Journal of studies on alcohol, 60 6
M. Olaithe, M. Pushpanathan, D. Hillman, P. Eastwood, M. Hunter, T. Skinner, A. James, K. Wesnes, R. Bucks (2020)Cognitive profiles in obstructive sleep apnea: a cluster analysis in sleep clinic and community samples.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
F. Altice, A. Kamarulzaman, V. Soriano, M. Schechter, G. Friedland (2010)Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
The Lancet, 376
M. Strand, V. Vindenes, H. Gjerde, J. Mørland, J. Ramaekers (2018)A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers
British Journal of Clinical Pharmacology, 85
M. Copenhaver, R. Shrestha, Jeffrey Wickersham, Damian Weikum, F. Altice (2016)An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance Therapy.
Journal of substance abuse treatment, 63
V. Savalei, Y. Rosseel (2021)Computational Options for Standard Errors and Test Statistics with Incomplete Normal and Nonnormal Data in SEM
Structural Equation Modeling: A Multidisciplinary Journal, 29
Nira Cedres, Alejandra Machado, Yaiza Molina, P. Diaz-Galvan, J. Hernández-Cabrera, J. Barroso, E. Westman, D. Ferreira (2019)Subjective Cognitive Decline Below and Above the Age of 60: A Multivariate Study on Neuroimaging, Cognitive, Clinical, and Demographic Measures.
Journal of Alzheimer's disease : JAD, 68 1
R. Heaton, D. Franklin, R. Deutsch, S. Letendre, R. Ellis, K. Casaletto, M. Marquine, S. Woods, F. Vaida, J. Atkinson, T. Marcotte, J. McCutchan, A. Collier, C. Marra, D. Clifford, B. Gelman, N. Sacktor, S. Morgello, D. Simpson, I. Abramson, A. Gamst, C. Fennema-Notestine, David Smith, I. Grant, D. Franklin, Terry Alexander, E. Capparelli, M. Dawson, Michael Taylor, R. Theilmann, Clint Cushman, J. Marquie‐Beck, J. McArthur, Vincent Rogalski, D. Simpson, Letty Mintz, Will Toperoff, C. Marra, Trudy Jones, Eleanor Head, M. Al-Lozi, M. Teshome (2015)Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 60 3
Tania Huedo-Medina, R. Shrestha, M. Copenhaver (2016)Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment
AIDS and Behavior, 20
A. Verdéjo-Garcia, Francisca López-Torrecillas, Carmen Giménez, M. Pérez-García (2004)Clinical Implications and Methodological Challenges in the Study of the Neuropsychological Correlates of Cannabis, Stimulant, and Opioid Abuse
Neuropsychology Review, 14
L. RadloffThe CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link
Egon Hagen, M. Sømhovd, M. Hesse, E. Arnevik, Aleksander Erga (2019)Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-A - The significance of psychiatric symptoms.
Journal of substance abuse treatment, 97
四井 賢一郎 (1998)THE WINDOWS
Voices of Modern Greece
F. Schmid, F. Benzerouk, S. Barrière, Audrey Henry, F. Limosin, A. Kaladjian, F. Gierski (2020)Heterogeneity of Executive Function Abilities in Recently Detoxified Patients with Alcohol Use Disorder: Evidence from a Cluster Analysis.
Alcoholism, clinical and experimental research
Odilia Yim, Kylee Ramdeen (2015)Hierarchical Cluster Analysis: Comparison of Three Linkage Measures and Application to Psychological Data
M. Copenhaver, Victoria Sanborn, R. Shrestha, C. Mistler, J. Gunstad (2020)Association between the brief inventory of neurocognitive impairment (BINI) and objective cognitive testing among persons with opioid use disorders in drug treatment
Journal of Addictive Diseases, 39
M. Schiltenwolf, M. Akbar, A. Hug, U. Pfüller, S. Gantz, E. Neubauer, H. Flor, Haili Wang (2014)Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids.
Pain physician, 17 1
Abhishek Ghosh, D. Basu, S. Mattoo, Devender Rana, Fazle Roub (2020)Does Cannabis Dependence Add on to the Neurocognitive Impairment Among Patients With Opioid Dependence? A Cross-Sectional Comparative Study.
The American journal on addictions
S. Yeoh, A. Holmes, M. Saling, I. Everall, A. Nicoll (2018)Depression, fatigue and neurocognitive deficits in chronic hepatitis C
Hepatology International, 12
Abstract Background Neurocognitive dysfunction is common among individuals with opioid use disorders (OUD) and can impede a range of treatment outcomes. We developed the 57-item Brief Inventory of Neuro-cognitive Impairment (BINI) to help detect and monitor neurocognitive dysfunction in the context of drug treatment settings. To date, no study has examined the possible presence of BINI subgroups among OUD patients, which could enhance our ability to tailor intervention strategies to meet individual treatment needs. The purpose of this study was to conduct a latent profile analysis to identify BINI subgroups that differ in terms of their reported and objective neurocognitive dysfunction. We hypothesized that subgroups would emerge, suggesting the potential benefit of implementing tailored strategies for optimal treatment outcomes. Methods Latent profile analyses included data from opioid-dependent patients (N = 177) enrolled in a methadone maintenance treatment program between July 2018 and October 2019. Results We found three profiles of self-reported neurocognitive symptoms, including those with 1) minimal concerns 2) moderate concerns, and 3) many concerns across multiple domains. Conclusions If these results are confirmed, the BINI may be used to rapidly identify persons who require specific accommodation strategies to improve their drug treatment outcomes.
Journal of Addictive Diseases – Taylor & Francis
Published: Apr 3, 2023
Keywords: Neurocognitive dysfunction; cognitive impairment; opioid dependence; drug treatment; BINI; medication for opioid use disorder; methadone maintenance
Access the full text.
Sign up today, get DeepDyve free for 14 days.